Codagenix Inc: COVI-VAC

Vaccine Type: Live-Attenuated

Vaccine Trial & Approval Tracker

This vaccine has reached Phase 3 trials.

About Trial Phases

Phase 1: 2 Trials

  • NCT04619628
    United Kingdom of Great Britain and Northern Ireland
  • NCT05233826
    United Kingdom of Great Britain and Northern Ireland

Phase 2: 0 Trials

There are no trials for this phase.

Phase 3: 1 Trial

Approvals

This vaccine is not yet approved.

Registered Trials